BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1724766)

  • 1. Management of disseminated midgut carcinoid tumours.
    Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
    Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolisation therapy in the midgut carcinoid syndrome: just tumour ischaemia?
    Wängberg B; Geterud K; Nilsson O; Jansson S; Dahlström A; Tylén U; Ahlman H
    Acta Oncol; 1993; 32(2):251-6. PubMed ID: 7686767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
    Wängberg B; Westberg G; Tylén U; Tisell L; Jansson S; Nilsson O; Johansson V; Scherstén T; Ahlman H
    World J Surg; 1996 Sep; 20(7):892-9; discussion 899. PubMed ID: 8678968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of liver metastases of carcinoid tumors.
    Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
    World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
    Odurny A; Birch SJ
    Clin Radiol; 1985 Nov; 36(6):597-602. PubMed ID: 2415290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
    Jermendy G; Kónya A; Kárpáti P
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
    Norton JA; Kerlan RK
    Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L; Persson G; Franzén S; Ahrén B
    Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
    Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
    Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery in patients with advanced midgut carcinoid tumours.
    Ahlman H
    Digestion; 1996; 57 Suppl 1():86-7. PubMed ID: 8813479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, surgical and medical aspect of the midgut carcinoids.
    de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
    Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
    Schell SR; Camp ER; Caridi JG; Hawkins IF
    J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
    Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
    Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor].
    Goñi F; Oleaga A; Goñi MJ; Monreal M; Yoldi A; González A; Llorente I; Moncada E
    Rev Clin Esp; 1991 Nov; 189(7):331-4. PubMed ID: 1722585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
    Janson ET; Oberg K
    Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolization of the liver in the management of metastatic carcinoid tumors.
    Mårtensson H; Nobin A; Bengmark S; Lunderquist A; Owman T; Sandén G
    J Surg Oncol; 1984 Nov; 27(3):152-8. PubMed ID: 6208426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryosurgical debulking of unresectable liver metastases for palliation of carcinoid syndrome.
    Johnson LB; Krebs T; Wong-You-Cheong J; Njoku M; Plotkin JS; Daly B; Wilson S; Kuo PC
    Surgery; 1997 Apr; 121(4):468-70. PubMed ID: 9122880
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome.
    Wängberg B; Ahlman H; Tylén U; Nilsson O; Hermodsson S; Hellstrand K
    Br J Cancer; 1995 Mar; 71(3):617-8. PubMed ID: 7880747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
    Linkesch M; Kuzmits R; Geyer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.